The ERBB4–ICD complex is inhibited both by Hippo signaling and by WWOX oxidoreductases, which compete with ERBB4–ICD for the binding to YAP, thus potentially accounting for WWOX tumor-suppressive activities in osteosarcomas [70]. The gene discussed is YAP1; the disease is neoplasm.